Cardiac Injury
Top CV, COVID-19 news: Panel on evolving knowledge, safety of RAAS antagonists and more
Healio and Cardiology Today present the most-read articles on COVID-19 and the heart.
Gradual return to exercise after COVID-19 requires ‘cautious approach’
In patients with COVID-19, the severity of the disease and the possibility of CV involvement should be taken into account when considering a return to intense exercise training and competition.
Critical care cardiologists suited to help combat COVID-19
Critical care cardiologists may be uniquely experienced to help manage clinical manifestations of the virus that causes COVID-19 and supplement the staff of noncardiac and COVID-19-specific ICUs, according to a report published in the Journal of the American College of Cardiology.
Top cardiology news in March: COVID-19 and the heart, plant-based benefit and more
Healio and Cardiology Today have compiled a list of the most-read news published in March.
Clinical review of COVID-19 and CVD: What the cardiovascular practitioner needs to know
This summary reviews the evolving molecular and clinical data on COVID-19, with a focus on the intersection of this virus with CVD and its potential impact on patients with CV and professionals.
Mavacamten shows promise in nonobstructive hypertrophic cardiomyopathy
In patients with nonobstructive hypertrophic cardiomyopathy, treatment with mavacamten was well tolerated and reduced biomarkers of cardiac injury and wall stress, according to results of the phase 2 MAVERICK-HCM study.
Cardiac injury confers greater mortality in patients with COVID-19
Among patients with laboratory-confirmed COVID-19 in Wuhan, China, those with cardiac injury had a higher risk for in-hospital mortality than patients without cardiac injury.